Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 265-053-6 | CAS number: 64741-52-2 A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100°F (19cSt at 40°C). It contains relatively few normal paraffins.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
No specific quantitative disposition and pharmacokinetic / toxicokinetic studies have been conducted with unrefined / acid treated base oils. Pharmacokinetic / metabolic studies of more highly refined base oils have shown that hydrocarbon components of base oils are absorbed in the gut, can be detected in the blood and lymphatic system, are further transported and may be deposited in the liver, lymph nodes, spleen and other organs and fat-soluble depots. The amount and degree of absorption, distribution, metabolism and excretion of paraffinic, cycloparaffinic and aromatic hydrocarbons depends in general on molecular weight, viscosity of oil and carbon number; carbon numbers greater than C30 will generally not be absorbed well, and carbon numbers less than C18 will be relatively rapidly transformed and / or eliminated. Disposition of hydrocarbons following inhalation exposure is expected to mimic ingestion exposure with a similar degree of Absorption, Distribution, Metabolism and Excretion (ADME) based on the physical parameters of the oil, however the lighter hydrocarbons (<C18) will be present in higher proportions in air than in the oil itself. Absorption of hydrocarbons following dermal exposure is expected to be significantly less than by oral and inhalation routes, with differential penetration capabilities based on molecular weight and carbon number and type. However, the impact to the immediate dermal area can be of significant consequence to health as evidenced by data for polycyclic aromatic constituents (PAC) in chronic dermal administration studies of unrefined and acid treated oils as described below.
No metabolism studies have been reported for unrefined / acid treated oils but studies have been reported on the metabolism of C16 and C18 hydrocarbons that are constituents of these oils. In these studies it has been shown that the hydrocarbons are metabolised to the corresponding fatty acids of the same carbon chain length as the parent hydrocarbons, suggesting a process of omega oxidation (Baldwinet al., 1992). Stetten (1943) administered mineral oil containing deuterated hexadecane to rats and monkeys. The deuterium was found to be incorporated into palmitic acid, a fatty acid.
McCarthy (1964), using octadecane and hexadecane, confirmed that these hydrocarbons were metabolised to C18 and C16 fatty acids, respectively, in goats, rats and chickens.
No studies have been carried out in man with unrefined / acid treated oils. However, there have been several case reports of the appearance of oil droplets in the spleen, liver and abdominal lymph nodes of people known to or believed to have ingested large quantities of highly refined mineral oil (Boitnott and Margolis, 1970; Stryker, 1941; Cruikshank and Thomas, 1984) or have been exposed to highly refined mineral oils through the food supply. Dincsoy et al. (1982) reported forty cases of lipogranulomas in non-fatty human livers and attributed the finding to ingestion of saturated hydrocarbons, like mineral oil, that are used widely in the food industry. Other reports of the occurrence of tissue accumulation of mineral oils after prolonged exposure, including prolonged usage as laxatives include Wiland and Smith (1957), Rose and Liber (1966), Liber and Rose (1967), Cruickshank (1984) and Blewittet al. (1977). It would be anticipated that unrefined or acid-treated oil components with viscosities similar to the highly refined mineral oils described above would also be retained in certain organs and fat-soluble depots were they to gain entrance into the human body.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.